Detection of gastric cancer using 18F-FLT PET: Comparison with 18F-FDG PET

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 3, 2009, Pages 382-388

  Kameyama, Reiko ^a   Yamamoto, Yuka ^a   Izuishi, Kunihiko ^a   Takebayashi, Ryusuke ^a   Hagiike, Masanobu ^a   Murota, Makiko ^a   Kaji, Masato ^b   Haba, Reiji ^c   Nishiyama, Yoshihiro ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY HOSPITAL   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

Author keywords

18F FDG; 18F FLT; Gastric cancer; Ki 67; PET

Indexed keywords

3' FLUOROTHYMIDINE F 18; FLUORODEOXYGLUCOSE F 18; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; POSITRON EMISSION TOMOGRAPHY; STOMACH CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; DIDEOXYNUCLEOSIDES; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 60549114858     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0970-3     Document Type: Article

References (36)

1. R Hustinx F Bénard A Alavi 2002 Whole-body FDG-PET imaging in the management of patients with cancer Semin Nucl Med 32 35 46
2. JB Bomanji DC Costa PJ Ell 2001 Clinical role of positron emission tomography in oncology Lancet Oncol 2 157 64
3. HW Yeung H Macapinlac M Karpeh RD Finn SM Larson 1998 Accuracy of FDG-PET in gastric cancer. Preliminary experience Clin Positron Imaging 1 213 21
4. A Stahl K Ott WA Weber K Becker T Link JR Siewert 2003 FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings Eur J Nucl Med Mol Imaging 30 288 95
5. E Mochiki H Kuwano H Katoh T Asao N Oriuchi K Endo 2004 Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer World J Surg 28 247 53
6. J Chen JH Cheong MJ Yun J Kim JS Lim WJ Hyung 2005 Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography Cancer 103 2383 90
7. A Yamada K Oguchi M Fukushima Y Imai M Kadoya 2006 Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression Ann Nucl Med 20 597 604
8. K Mukai Y Ishida K Okajima H Isozaki T Morimoto S Nishiyama 2006 Usefulness of preoperative FDG-PET for detection of gastric cancer Gastric Cancer 9 192 6
9. J Tian L Chen B Wei M Shao Y Ding S Yao 2004 The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies Nucl Med Commun 25 825 31
10. T Yoshioka K Yamaguchi K Kubota T Saginoya T Yamazaki T Ido 2003 Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer J Nucl Med 44 690 9
11. PD Shreve Y Anzai RL Wahl 1999 Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants Radiographics 19 61 77
12. H Koga M Sasaki Y Kuwabara K Hiraka M Nakagawa K Abe 2003 An analysis of the physiological FDG uptake pattern in the stomach Ann Nucl Med 17 733 8
13. AF Shields JR Grierson BM Dohmen HJ Machulla JC Stayanoff JW Lawhorn-Crews 1998 Imaging proliferation in vivo with [F-18]FLT and positron emission tomography Nat Med 4 1334 6
14. JS Rasey JR Grierson LW Wiens PD Kolb JL Schwartz 2002 Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells J Nucl Med 43 1210 7
15. DL Francis A Freeman D Visvikis DC Costa SK Luthra M Novelli 2003 In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography Gut 52 1602 6
16. HL van Westreenen DC Cobben PL Jager HM van Dullemen J Wesseling PH Elsinga 2005 Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer J Nucl Med 46 400 4
17. AK Buck G Halter H Schirrmeister G Halter P Möller C Kratochwil 2003 Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG J Nucl Med 44 1426 31
18. H Dittmann BM Dohmen F Paulsen K Eichhorn SM Eschmann M Horger 2003 [18F]FLT PET for diagnosis and staging of thoracic tumours Eur J Nucl Med Mol Imaging 30 1407 12
19. K Herrmann K Ott AK Buck F Loedick D Wilhem M Souvatzoglou 2007 Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis J Nucl Med 48 1945 50
20. HJ Machulla A Blocher M Kuntzsch JR Grierson 2000 Simplified labeling approach for synthesizing 3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT) J Radioanal Nucl Chem 24 843 6
21. SA Toorongian GK Mulholland DM Jewett MA Bachelor MR Kilbourn 1990 Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin Nucl Med Biol 17 273 9
22. Hamilton SR, Aaltonen LA. Tumours of the stomach. WHO classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 38-52.
23. DL Francis D Visvikis DC Costa TH Arulampalam C Townsend SK Luthra 2003 Potential impact of [18F] 3′-deoxy-3′-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer Eur J Nucl Med Mol Imaging 30 988 4
24. C Yap D Vranjesevic R Cameron J Czernin 2003 F18-fluorine-thymidine; a new molecular probe for PET imaging of cancer (abstract) Ann Surg Oncol 10 S38
25. DC Cobben BF van der Laan B Maas W Vaalburg AJ Suurmeijer HJ Hoekstra 2004 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET J Nucl Med 45 226 31
26. B Smyczek-Gargya N Fersis H Dittmann U Vogel G Reischl HJ Machulla 2004 PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study Eur J Nucl Med Mol Imaging 31 720 4
27. A Costa R Silvestrini C Mochen C Legiaglie P Boracchi A Faramda 1996 P53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung cancer Br J Cancer 73 914 9
28. T Konishi T Miyama S Sakamoto T Hirata K Mafune M Hiraishi 1992 Activities of thymidylate synthetase and thymidine kinase in gastric cancer Surg Oncol 1 215 21
29. T Scholzen J Gerdes 2000 The Ki-67 protein: from the known and the unknown J Cell Physiol 182 311 22
30. F Spyratos M Ferrero-Poüs M Trassard K Hacène E Phillips M Tubiana-Hulin 2002 Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value Cancer 94 2151 9
31. JL Schwartz Y Tamura R Jordan JR Grierson KA Krohn 2003 Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs J Nucl Med 44 2027 32
32. B Munch-Petersen L Cloos HK Jensen G Tyrsted 1995 Human thymidine kinase 1. Regulation in normal and malignant cells Adv Enzyme Regul 35 69 89
33. B Munch-Petersen G Tyrsted l Cloos 1993 Reversible ATP-dependent transition between two forms of human cytosolic thymidine kinase with different enzyme properties J Biol Chem 268 15621 5
34. H Barthel MC Cleuj DR Collingridge OC Hutchinson S Osman Q He 2003 3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography Cancer Res 63 3791 8
35. A Dimitrakopoulou-Strauss LG Strauss 2008 The role of 18F-FLT in cancer imaging: does it really reflect proliferation? Eur J Nucl Med Mol Imaging 35 523 6
36. K Ott K Herrmann F Lordick H Wieder WA Weber K Becker 2008 Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study Clin Cancer Res 14 2012 8